English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background Human papillomavirus (HPV) is strongly linked to the pathogenesis of cervical dysplasia; women with IBD may be at greater risk of developing cervical pathology, especially those on immunosuppressive therapies. In Ireland a national screening programme begins at age 25 and continues until age 60. This was a preliminary study looking at the number of women seen at our IBD clinic with a prior abnormal smear test, and the correlation to their medication history. Methods All women attending our IBD service, over an 8 week duration, were asked to complete a questionnaire regarding previous smear testing and results. We also looked at their diagnosis, years since diagnosis and medication history. Any patient who was referred on for a colposcopy was considered as having an abnormal smear. Results A total of 80 women with an average age of 51.5 years (SD ±±33.5) and with an average 20.8 years (SD ±±20.2) since diagnosis had been screened. 10 were under the age of 25 and thus excluded, of these 7 were vaccinated against HPV. Seven women who were eligible, had never had a smear and therefore excluded. A total of 63 women previously had a smear test in their lifetime. Conclusion Conclusion Our study shows that women in our IBD cohort have a significantly higher risk of having an abnormal smear vs. the average Irish women (23.8% vs. national average of 9.8%, p = 0.006). Furthermore, the majority (80%, p &amp;lt; 0.001) of these patients were on immunosuppressive therapy at the time of the abnormal smear test. While the conclusion we can draw from this study are limited, we believe it emphasises the need for stringent adherence by IBD patients to screening guidelines for early detection of cervical dysplasia.

P756 Cervical smear screening results amongst women with inflammatory bowel disease at an Irish hospital